Pharmaceutical companies are facing a potential hit as President Trump considers imposing tariffs on pharmaceutical imports, causing stock prices to fall. Companies like Johnson & Johnson, Eli Lilly, and Merck are already investing billions in expanding their manufacturing in the US in anticipation of the tariffs. European-based companies like AstraZeneca and GSK are also monitoring the situation closely, as trade groups warn of a potential shift to the US market if the EU does not strengthen its regulations.
Full Article
Oregon cop’s offer of a cigarette leads to a confession and a body: “Smokin’ and jokin'”
On October 2, 2017, Aaron Friar, 50, and his daughter Ellie, 15, disappeared from their Medford, Oregon home, prompting an investigation that revealed signs of foul play, including blood spatter at the scene. Ellie was found alive shortly after, walking with her boyfriend and a friend, while her father's whereabouts remained unknown, leading detectives to suspect a homicide. During questioning, Russell Jones, one of the men with Ellie, eventually confessed to assisting in disposing of...
Read more